(lp0
S"GALENA BIOPHARMA, INC.  Files An 8-K Notice of Delisting or ... Market Exclusive - 8 hours ago On March 24, 2017, Galena Biopharma, Inc.  received a notice  from The NASDAQ Stock Market  stating that the closing bid price for the Company's common stock had been below $1.00 per share for the previous 30&nbsp;...Galena Biopharma Inc.  Soars 6.01% on March 27 - Equities.comGalena Biopharma Inc  Short Interest Update - Chaffey Breeze"
p1
aS'Galena Biopharma Inc  Hires Canaccord Genuity to Advise on Strategic ... Smarter Analyst - Mar 9, 2017 Galena Biopharma Inc  announced it has engaged Canaccord Genuity, Inc. as its financial advisor to assist in the previously announced strategic alternative review process.Most Active Stock: Galena Biopharma, Inc.  - HugoPressThe Galena Biopharma, Inc.  Given Consensus Recommendation of Hold by ... - DailyQuint'
p2
aS'Stock Update : Galena Biopharma Inc Announces 4Q and Year End ... Smarter Analyst - Mar 15, 2017 Galena Biopharma Inc  reported its financial results for the quarter and year ended December 31, 2016. I am honored to be selected by the Board of Directors to lead Galena as we explore the best possible outcome for the company and its&nbsp;...Galena Biopharma reports 4Q loss - Yahoo FinanceHot Stock to Watch: Galena Biopharma, Inc.  - HugoPress'
p3
aS'SHAREHOLDER ALERT: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Business Wire  - Mar 27, 2017 IRVINE, Calif.----Khang &amp; Khang LLP  announces a class action lawsuit against Galena Biopharma, Inc.  . Investors who purchased or otherwise acquired shares between August 11,&nbsp;...'
p4
aS"Galena Biopharma, Inc.  Shares on the Rise Amid Positive Clinical Trial Data Smarter Analyst - Mar 17, 2017 Galena Biopharma Inc  investors have a smile on their faces Friday morning, after the drug maker announced positive data from the Company's GALE-301  investigator-sponsored Phase 1/2a clinical trial."
p5
aS'Galena Biopharma, Inc.  Technicals Are Painting A Bleak Picture USA Commerce Daily - 15 hours ago With all other things going on, Galena Biopharma, Inc.  has been on a free fall - declining -68.09 percent in just three months.'
p6
aS'Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against ... Yahoo Finance - Mar 17, 2017 NEW YORK, NY / ACCESSWIRE / March 17, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Galena Biopharma, Inc.  investors who purchased Galena stock between August 11, 2014 and January 31, 2017, inclusive (the&nbsp;...'
p7
aS'GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of ... Yahoo Finance - Mar 17, 2017 NEW YORK, March 17, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities  from August 11, 2014 through January 31, 2017, both dates inclusive &nbsp;...'
p8
aS"Today's Brokerage Rating: Galena Biopharma, Inc. , BioScrip, Inc ... StockNewsJournal - Mar 23, 2017 Galena Biopharma, Inc. , at its latest closing price of $0.57, it has a price-to-book ratio of 0.31, compared to an industry average at 4.13.The Galena Biopharma Inc  Raised to Strong-Buy at Zacks Investment Research - Petro Global News 24Galena Biopharma Inc  Upgraded by Zacks Investment Research to Strong-Buy - Chaffey Breeze"
p9
aS'Traders Secrets on Callaway Golf Company , Galena Biopharma, Inc.  StockNewsJournal - Mar 22, 2017 Galena Biopharma, Inc. , at its latest closing price of $0.59, it has a price-to-book ratio of 0.33, compared to an industry average at 4.12.'
p10
a.